NasdaqGS - Delayed Quote USD

Inogen, Inc. (INGN)

8.46 +0.23 (+2.79%)
At close: 4:00 PM EDT
8.51 +0.05 (+0.59%)
After hours: 4:15 PM EDT
Advanced Chart
Loading Chart for INGN
DELL
  • Previous Close 8.23
  • Open 8.17
  • Bid 8.43 x 100
  • Ask 8.51 x 100
  • Day's Range 8.16 - 8.48
  • 52 Week Range 4.13 - 11.98
  • Volume 132,886
  • Avg. Volume 290,834
  • Market Cap (intraday) 199.462M
  • Beta (5Y Monthly) 1.07
  • PE Ratio (TTM) --
  • EPS (TTM) -4.16
  • Earnings Date Aug 5, 2024 - Aug 9, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 7.00

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

www.inogen.com

834

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

More about Inogen, Inc.

Recent News: INGN

View More
View More

Performance Overview: INGN

Trailing total returns as of 6/6/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

INGN
54.10%
S&P 500
12.23%

1-Year Return

INGN
15.48%
S&P 500
25.25%

3-Year Return

INGN
86.72%
S&P 500
26.55%

5-Year Return

INGN
86.61%
S&P 500
89.41%

Compare To: INGN

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

INGN
Inogen, Inc.
8.46
+2.79%
Mkt Cap 199.462M
Industry Medical Devices
NVRO
Nevro Corp.
9.45
+1.94%
Mkt Cap 347.085M
Industry Medical Devices
CTKB
Cytek Biosciences, Inc.
5.97
+4.19%
Mkt Cap 783.7M
Industry Medical Devices
IART
Integra LifeSciences Holdings Corporation
31.11
-2.05%
Mkt Cap 2.451B
Industry Medical Devices
VREX
Varex Imaging Corporation
15.75
-0.63%
Mkt Cap 643.482M
Industry Medical Devices
OFIX
Orthofix Medical Inc.
13.54
-3.22%
Mkt Cap 508.147M
Industry Medical Devices
MODD
Modular Medical, Inc.
1.5650
-0.95%
Mkt Cap 48.499M
Industry Medical Devices
SGHT
Sight Sciences, Inc.
6.91
-3.36%
Mkt Cap 343.816M
Industry Medical Devices
AXNX
Axonics, Inc.
67.13
-0.07%
Mkt Cap 3.425B
Industry Medical Devices
LUNG
Pulmonx Corporation
7.08
+0.28%
Mkt Cap 274.816M
Industry Medical Devices
CVRX
CVRx, Inc.
9.42
+8.40%
Mkt Cap 203.431M
Industry Medical Devices

Statistics: INGN

View More

Valuation Measures

Annual
As of 6/5/2024

  • Market Cap

    194.04M

  • Enterprise Value

    96.34M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.60

  • Price/Book (mrq)

    1.01

  • Enterprise Value/Revenue

    0.30

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -30.07%

  • Return on Assets (ttm)

    -10.65%

  • Return on Equity (ttm)

    -40.86%

  • Revenue (ttm)

    321.52M

  • Net Income Avi to Common (ttm)

    -96.68M

  • Diluted EPS (ttm)

    -4.16

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    119.81M

  • Total Debt/Equity (mrq)

    11.52%

  • Levered Free Cash Flow (ttm)

    3.84M

View More

Research Analysis: INGN

View More

Analyst Price Targets

7.00 Low
7.00 Average
8.46 Current
7.00
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 
View More

Company Insights: INGN

Research Reports: INGN

View More

  • Lowering target price to $8.00

    INOGEN INC has an Investment Rating of SELL; a target price of $8.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.

    Rating
    Price Target
    Argus• 11 months ago
     

  • Raising target price to $9.00

    INOGEN INC has an Investment Rating of SELL; a target price of $9.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.

    Rating
    Price Target
    Argus• 11 months ago
     

  • Lowering target price to $8.00

    INOGEN INC has an Investment Rating of SELL; a target price of $8.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.

    Rating
    Price Target
    Argus• last year
     

  • What does Argus have to say about INGN?

    INOGEN INC has an Investment Rating of SELL; a target price of $9.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.

    Rating
    Price Target
    Argus• last year
     
View More

People Also Watch

ICUI ICU Medical, Inc.
108.34
+0.14%
 
NVRO Nevro Corp.
9.45
+1.94%
 
MMSI Merit Medical Systems, Inc.
83.56
+0.28%
 
GKOS Glaukos Corporation
113.96
-0.65%
 
LGND Ligand Pharmaceuticals Incorporated
82.37
-1.47%
 
LMAT LeMaitre Vascular, Inc.
77.79
-3.28%
 
IART Integra LifeSciences Holdings Corporation
31.11
-2.05%
 
IRTC iRhythm Technologies, Inc.
97.85
+8.11%
 
ENTA Enanta Pharmaceuticals, Inc.
12.54
+1.21%
 
HQY HealthEquity, Inc.
83.69
-1.36%
 
OFIX Orthofix Medical Inc.
13.54
-3.22%
 
NEOG Neogen Corporation
16.21
+1.25%
 
TCMD Tactile Systems Technology, Inc.
12.18
+0.58%
 
LIVN LivaNova PLC
52.80
-12.04%
 
EGRX Eagle Pharmaceuticals, Inc.
3.7300
-6.75%
 
ITGR Integer Holdings Corporation
121.00
+0.11%